Clotblog with Dr Samuel GoldhaberView all posts »
Screening for lipoprotein(a) instead of CRP: Have the EAS guidelines lost their way?Sep 15, 2010 09:40 EDT
The European Atherosclerosis Society endorses screening for lipoprotein(a) but remains silent on screening for high-sensitivity C-reactive protein despite a sizable body of evidence pointing to CRP as a valuable biomarker of vascular disease risk. What can explain this position?
Do you use CRP to assess risk of vascular disease?
Will the EAS screening recommendations influence your clinical practice?
Goldhaber SZ. European Atherosclerosis Society screening recommendations for lipoprotein(a) and high-sensitivity c-reactive protein: Double standard or failure of evidence-based medicine? Clin Chem 2010. Available here.